Physician profile
Mark A Freeborn
NPI 1821107756
$1,791,406.58
in general payments reported to CMS, 2019-2025
16 companies · $292K in 2025
The $292K reported for 2025 was more than what 97% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152K · 2020: $83K · 2021: $201K · 2022: $189K · 2023: $594K · 2024: $279K · 2025: $292K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $818K · Royalty Or License: $275K · Travel and Lodging: $64K · Food and Beverage: $7,562 · Education: $1,583.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $818,124.00 |
| Royalty Or License | $275,000.00 |
| Travel and Lodging | $63,753.64 |
| Food and Beverage | $7,561.54 |
| Education | $1,583.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $1,209,301.70 | 2019-2023 | Pulse, Alif, Xlif |
| Globus Medical, INC. | $570,376.42 | 2022-2025 | Xlif, Excelsius Gps, Alif |
| Alphatec Spine, INC | $2,720.30 | 2021-2024 | Other - Miscellaneous, Solus Alif |
| Summit Surgical Corp. | $2,209.67 | 2023 | |
| Mml US, INC. | $1,931.19 | 2022-2025 | Reactiv8 |
| Seaspine Orthopedics Corporation | $1,205.53 | 2019-2021 | |
| Invictus Surgical Incorporated | $1,009.11 | 2024-2025 | |
| Orthofix Medical, INC. | $1,005.96 | 2019-2023 | Northstar |
| Stryker Corporation | $417.59 | 2021-2024 | Gamma, Tritanium Pl |
| Medtronic, INC. | $416.98 | 2024-2025 | Unid_pass |
| Relievant Medsystems, INC. | $212.61 | 2019-2021 | |
| Augmedics INC. | $180.47 | 2024 | Xvision |
| Viseon, INC. | $151.28 | 2021 | |
| Surgalign Spine Technologies, INC. | $146.98 | 2021 | |
| Arthrex, INC. | $100.42 | 2024-2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $20.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Freeborn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.